Tag Archives: antibody cocktail

DOD, HHS to Procure More Doses of Regeneron’s COVID-19 Antibody Under Potential $2.6B Deal

COVID-19

Regeneron Pharmaceuticals (Nasdaq: REGN) will supply an additional 1.25M treatment courses of an antibody cocktail composed of casirivimab and imdevimab to the U.S. government under a potential $2.63B agreement with the departments of Defense and Health and Human Services.

Read More »